Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare safety, efficacy and procedural outcome of percutaneous PDA closure using different approaches for better characterization of device selection criteria.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure

NCT05321849

Echocardiography PDA

COMPLETED

Transcatheter Versus Surgical Closure of Ventricular Septal Defect: A Comparative Study

NCT05306483

Heart Defects, Congenital

COMPLETED NA

Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy

NCT04083729

Pulmonary Hypertension

UNKNOWN NA

Clinical Outcomes in Fenestrated Extra-Cardiac Fontan in Low Preoperative Risk Profiles

NCT03503032

Fontan Procedure

COMPLETED

Improvement In Left Ventricular Diameter After Closure Of ASD With Fenestrated Patch: A Cross-sectional Study

NCT06139679

Atrial Septal Defect

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous PDA closure

transcatheter patent ductus arteriosus closure

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients who are candidate for transcatheter PDA closure

Exclusion Criteria

1. Patients with PDA dependent pulmonary circulation.
2. Patients with small sized PDA which is silent by auscultation
3. Patients with large sized PDA which is unsuitable for Trans-catheter closure
4. Patients with PDA and severe irreversible pulmonary hypertension (Eisenmenger's syndrome) (7).
5. Patients with active infection or active infective endarteritis.
6. Patients refusing the study.

Minimum Eligible Age

1 Month

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No